ArticleEuropean heart journal2021

Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.

Kazuma Oyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.